A 48-year-old patient with IgA k multiple myeloma received a BMT from his HLA-matched sibling, After transplantation, the disease relapsed, Melphalan therapy followed by reinfusion of haemopoietic blood stem cells collected from the patient led to the improvement of the clinical status, although mixed chimerism and an elevated serum IgA persisted. Successful donor immunisation against an immunogenic preparation of the recipient monoclonal protein was performed before the infusion of donor T lymphocytes (DLI) into the patient. Ten weeks after the lymphocyte infusions, no monoclonal band was evidenced and donor complete chimerism was detected, The patient did not develop GVHD, Once complete remission was achieved, the idiotype vaccine was administered to the patient. Nineteen months after DLI, the patient remains in remission.
机构:
Univ Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USA
机构:
Univ Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Myeloma & Transplantat Res Ctr, Little Rock, AR 72205 USA